United States · Series D startup
8 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$100Mraised across 8 rounds since 2007, from 8 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
U.S. Venture Partners
New Leaf Venture Partners
Venture Investors
Endeavour VisionFrom a historical funding recordSEC filing: $38M sold, first sale Aug 2015
From a historical funding recordSEC filing: $8.8M sold, first sale Mar 2015
No investor was named in the report.
From a historical funding recordSEC filing: $6.8M sold, first sale Jan 2015
No investor was named in the report.
From a historical funding recordSEC filing: $4.0M sold, first sale Jun 2014
Reported by pevc.dowjones.comSEC filing: $16M sold, first sale Oct 2012
No investor was named in the report.
Reported by sec.govSEC filing: $1.5M sold, first sale May 2012
Reported by deals.venturebeat.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
New Leaf Venture PartnersU.S. Venture Partners
SVB Capital
Oxford Finance LLCVenture InvestorsEndeavour VisionHealthCor PartnersMissing a round, or an investor who was in one? Tell us.
ReShape Medical's investors include SV Life Sciences, New Leaf Venture Partners, U.S. Venture Partners, SVB Capital and Oxford Finance LLC, and 3 more on record.
ReShape Medical has raised $100M across 8 rounds since 2007.
ReShape Medical's most recent round was a Series D of $38M in Aug 2015.
Its most recent round, $38M in Aug 2015, is also its largest on record.
ReShape Medical's first round on record, in Aug 2007, was backed by SV Life Sciences and New Leaf Venture Partners.
ReShape Medical's latest named round is a Series D, in Aug 2015.
ReShape Medical is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·